Recalls, Market Withdrawals, & Safety Alerts
The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this page. See Additional information about recalls for a more complete listing.
The Recalls, Market Withdrawals & Safety Alerts are available on FDA’s website for three years before being archived. To search archived content, visit Search FDA Archive and input the name of the product and/or company name in the Search terms box as well as the year to get the most inclusive search results. To scroll through archived Recalls, Market Withdrawals & Safety Alerts content by year, see the Recall and Safety Alerts Archive.
Sign up to receive Recalls, Market Withdrawals and Safety Alerts.* FDA Employees: Use Chrome to Subscribe until further notice.
| Date | Brand Name(s) | Product Description | Product Type | Recall Reason Description | Company Name | Terminated Recall | Excerpt |
|---|---|---|---|---|---|---|---|
| Actavis | Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg | Drugs | Due to detection of N-Nitrosodimethylamine (NDMA) | Teva Pharmaceuticals USA Inc. | … Actavis … Teva Pharmaceuticals USA Inc. … Teva Pharmaceuticals USA, Inc. is voluntarily recalling … | ||
| GSMS Inc. | Losartan potassium tablets | Drugs, Generic Drugs | Detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) | Teva Pharmaceuticals USA, Inc. | Terminated | … GSMS Inc. … Teva Pharmaceuticals USA, Inc. … Teva Pharmaceuticals USA, Inc. has expanded its voluntary … |